dipyridamole has been researched along with cilazapril, anhydrous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Clozel, JP; Hefti, F | 1 |
| Futrakul, N; Futrakul, P; Kingwatanakul, P; Sensirivatana, R; Sitprija, V; Watana, D | 1 |
| Futrakul, N; Futrakul, P; Pochanugool, C; Poshyachinda, M; Sensirivatana, R; Singkhwa, V; Sitprija, V; Watana, D; Yenrudi, S | 1 |
| Chen, LG; Fujita, M; Hikai, T; Hosokawa, R; Inada, H; Konishi, J; Kudou, T; Masuda, D; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N | 1 |
5 other study(ies) available for dipyridamole and cilazapril, anhydrous
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cilazapril; Coronary Circulation; Dipyridamole; Heart; Hypertension; Male; Organ Size; Pyridazines; Rats; Rats, Inbred SHR; Regional Blood Flow | 1988 |
Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
Topics: Cilazapril; Dipyridamole; Disease Progression; Glomerulosclerosis, Focal Segmental; Heparin; Humans; Isradipine; Perfusion; Prednisolone; Renal Circulation | 1995 |
Renal dysfunction in glomerulonephropathy associated with rapid onset renal failure.
Topics: Acute Kidney Injury; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Anuria; Blood Flow Velocity; Calcium Channel Blockers; Child; Child, Preschool; Cilazapril; Dipyridamole; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis; Heparin; Humans; Isradipine; Kidney; Platelet Aggregation Inhibitors; Renal Plasma Flow; Treatment Outcome; Vascular Resistance | 1997 |
Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).
Topics: Aged; Aged, 80 and over; Ammonia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Coronary Circulation; Coronary Vessels; Dipyridamole; Electrocardiography; Heart Rate; Humans; Hypertension; Middle Aged; Nitrogen Radioisotopes; Pulse; Radiopharmaceuticals; Tomography, Emission-Computed; Vasodilator Agents | 2000 |